Dear Colleagues, Welcome to my PES monthly President’s Newsletters! I want to begin by expressing my heartfelt gratitude to Dr.…
More Articles
Name: Meredith Hanrahan Year: 3rd Year Medical Student (Class of 2022) Program: M.D. Program School: Geisinger Commonwealth School of Medicine What is your most memorable experience in…
Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc. and Biocon Ltd., was…
Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system. It was approved by…
These resources have been identified by members as being useful during these difficult times. They are provided as a reference only. Timely information about COVID-19 that is curated specifically for…
Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in the US at the…
In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery and deliver automated correction…
Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before meals, Fiasp may be dosed immediately…
In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy, changes have been made…
The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly) and a stable liquid…